Sort   by:  
 Page size 
UnknownAntibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab.
Not available
S-EPMC8927425 | biostudies-literature
UnknownNeutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903 | biostudies-literature
UnknownMetformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Not available
S-EPMC12303861 | biostudies-literature
UnknownCaffeine Consumption Contributes to Skin Intrinsic Fluorescence in Type 1 Diabetes.
Not available
S-EPMC4575521 | biostudies-literature
UnknownEpigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT/EDIC type 1 diabetes cohort.
Not available
S-EPMC4890596 | biostudies-literature
UnknownImpact of Excessive Weight Gain on Cardiovascular Outcomes in Type 1 Diabetes: Results From the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Not available
S-EPMC5711332 | biostudies-literature
UnknownGlycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.
Not available
S-EPMC5025347 | biostudies-literature
UnknownFrequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes.
Not available
S-EPMC5557280 | biostudies-literature
UnknownCareer intentions of medical students in the UK: a national, cross-sectional study (AIMS study).
Not available
S-EPMC10496670 | biostudies-literature
UnknownSerum urate and cardiovascular events in the DCCT/EDIC study.
Not available
S-EPMC8271014 | biostudies-literature
Sort   by:  
 Page size